Biotechnology Value Trading Fund OS LP's Net Worth

Estimate Recalculated Feb 10, 2025 11:26PM EST

Who is Biotechnology Value Trading Fund OS LP

Biotechnology Value Trading Fund OS LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Therapeutics Inc., IMMUNE DESIGN CORP., Oncothyreon Inc., XOMA Corp, Xenon Pharmaceuticals Inc., Cullinan Oncology, Inc., Merus N.V., Nivalis Therapeutics, Inc., Repare Therapeutics Inc., PIERIS PHARMACEUTICALS, INC., Verastem, Inc., Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, GLYCOMIMETICS INC, Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., Regulus Therapeutics Inc., ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., Third Harmonic Bio, Inc., FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., ARQULE INC, enGene Holdings Inc., and POINT Biopharma Global Inc..

SEC CIK

Biotechnology Value Trading Fund OS LP's CIK is 0001660683

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allakos Inc.

Investor

Updated Jan 26, 2024


Form 4	-100.00%	-8.63M	—	—	Jan 29, 2024	—	Disposition	—	Jan 25 - Jan 26
Form 4	47.80%	1.71M	$5.83	$9.97M	Nov 10, 2022	8.60M	Purchase	—	Nov 08
Form 4	20.43%	557.73K	$12.00	$6.69M	Jan 10, 2022	6.87M	Purchase	—	Jan 06 - Jan 07
Form 4	0.41%	11.03K	$13.94	$153.83K	Sep 23, 2021	6.31M	Purchase	—	Sep 21
Form 4	16.86%	392.27K	$16.49	$6.47M	Sep 15, 2021	6.30M	Purchase	—	Sep 13
Form 4	33.73%	587.00K	$15.47	$9.08M	Jul 06, 2021	5.91M	Purchase	—	Jul 01 - Jul 06
Form 4	7.63%	123.35K	$15.94	$1.97M	May 25, 2021	5.32M	Purchase	—	May 21 - May 24
Form 4	14.80%	208.47K	$16.59	$3.46M	May 20, 2021	5.20M	Purchase	—	May 18 - May 19
Form 4	4.30%	58.00K	$14.26	$827.17K	May 17, 2021	4.99M	Purchase	—	May 13
Form 4/A	522.18%	1.13M	$16.86	$19.10M	May 17, 2021	1.35M	Purchase	—	Apr 23 - Apr 26
Form 4	29.86%	1.13M	$16.86	—	Apr 27, 2021	4.93M	Options	—	Apr 23 - Apr 26
Form 3	—	—	—	—	Apr 27, 2021	—	—	—	—


Form 4	-15.77%	-902.00K	$1.83	-$1.65M	Dec 04, 2018	4.82M	Sale	—	Dec 04
Form 3	—	—	—	—	Nov 09, 2018	5.72M	—	—	—


Form 4	—	17.25K	$800.00	$13.80M	Jun 27, 2016	23.83M	Grant	—	Jun 23
Form 3	—	—	—	—	Dec 22, 2015	18.80M	—	—	—


Form 4	—	10.97K	—	—	May 19, 2023	3.91M	Grant	—	May 17
Form 4	0.66%	22.25K	$19.15	$420.74K	Jan 09, 2023	3.90M	Purchase	—	Jan 05 - Jan 06
Form 4	0.73%	24.64K	$16.61	$409.31K	Sep 27, 2022	3.88M	Purchase	—	Sep 23 - Sep 27
Form 4	1.70%	56.31K	$17.70	$990.72K	Sep 16, 2022	3.85M	Purchase	—	Sep 14 - Sep 16
Form 4	—	9.00K	—	—	May 20, 2022	3.80M	Grant	—	May 18
Form 4	—	5.10K	—	—	May 21, 2021	3.79M	Grant	—	May 19
Form 4	-15.58%	-651.70K	$38.36	-$25.00M	Apr 02, 2021	3.78M	Sale	—	Mar 31
Form 4	—	200.00K	$25.00	$5.00M	Dec 15, 2020	4.43M	Purchase	—	Dec 11
Form 4	1.37%	51.37K	$18.34	$941.96K	Sep 23, 2020	4.23M	Purchase	—	Sep 21 - Sep 23
Form 4	0.21%	7.74K	$18.77	$145.23K	Sep 10, 2020	4.18M	Purchase	—	Sep 04
Form 4	0.96%	35.62K	$18.71	$666.48K	Sep 01, 2020	4.16M	Purchase	—	Aug 28 - Sep 01
Form 4	0.77%	28.18K	$19.41	$546.65K	Aug 25, 2020	4.13M	Purchase	—	Aug 21 - Aug 25
Form 4	0.31%	6.16K	$19.47	$120.00K	Aug 20, 2020	4.06M	Purchase	—	Aug 18 - Aug 20
Form 4	1.40%	27.02K	$18.46	$498.74K	Aug 14, 2020	4.06M	Purchase	—	Aug 12 - Aug 14
Form 4	52.51%	1.25M	$13.00	$16.29M	Apr 17, 2020	4.03M	Options	—	Apr 15
Form 4	0.65%	8.26K	$17.20	$142.13K	Mar 27, 2020	2.78M	Purchase	—	Mar 25
Form 4	0.35%	4.44K	$14.52	$64.47K	Mar 20, 2020	2.77M	Purchase	—	Mar 18
Form 4	10.31%	118.28K	$17.94	$2.12M	Mar 17, 2020	2.77M	Purchase	—	Mar 13 - Mar 17
Form 4	9.53%	373.19K	$22.00	$18.60M	Dec 20, 2019	4.53M	Purchase	—	Dec 18 - Dec 19
Form 4	3.88%	27.91K	$14.63	$408.23K	May 14, 2019	1.80M	Purchase	—	May 10 - May 14
Form 4	3.70%	25.68K	$28.63	$406.79K	Dec 19, 2018	1.78M	Purchase	—	Dec 14 - Dec 18
Form 4	5.55%	36.46K	$14.46	$527.24K	Dec 13, 2018	1.75M	Purchase	—	Dec 11 - Dec 13
Form 4	10.24%	61.02K	$14.71	$897.45K	Dec 10, 2018	1.71M	Purchase	—	Dec 06 - Dec 10
Form 4	1.67%	9.80K	$14.91	$146.14K	Dec 04, 2018	1.65M	Purchase	—	Nov 30 - Dec 04
Form 4	5.34%	29.70K	$15.10	$448.48K	Nov 29, 2018	1.64M	Purchase	—	Nov 27 - Nov 29
Form 4	14.92%	72.25K	$14.17	$1.02M	Nov 21, 2018	1.61M	Purchase	—	Nov 19 - Nov 21
Form 4	7.07%	31.99K	$13.48	$431.35K	Nov 19, 2018	1.54M	Purchase	—	Nov 15 - Nov 16
Form 3	—	—	—	—	Feb 21, 2017	1.50M	—	—	—


Form 4/A	2.94%	85.46K	$3.04	$259.47K	Jun 30, 2017	2.99M	Purchase	—	Jun 27
Form 3	—	—	—	—	Sep 12, 2016	2.50M	—	—	—


Form 4	-77.67%	-5.76M	—	—	Jan 19, 2023	1.66M	Disposition	—	Jan 19
Form 4	11.27%	751.40K	$11.00	$8.26M	Jun 03, 2022	7.42M	Purchase	—	Jun 01
Form 4	19.98%	1.11M	$9.09	$10.06M	May 16, 2022	6.66M	Purchase	—	May 12 - May 13
Form 4	5.55%	276.00K	$10.75	$2.97M	Apr 05, 2022	5.55M	Purchase	—	Apr 01
Form 3	—	—	—	—	Jan 10, 2022	5.28M	—	—	—


Form 4	-22.78%	-1.13M	$27.56	-$31.22M	Oct 08, 2021	3.84M	Sale	—	Oct 07 - Oct 08
Form 4	-30.54%	-2.19M	$20.75	-$45.36M	Jul 07, 2021	4.97M	Sale	—	Jul 02
Form 4	4.37%	300.00K	$19.75	$5.93M	Apr 01, 2021	7.16M	Purchase	—	Mar 30
Form 4	1.99%	79.50K	$22.75	$1.81M	Mar 24, 2021	6.86M	Purchase	—	Mar 22
Form 4	3.83%	250.00K	$23.00	$5.75M	Mar 18, 2021	6.78M	Purchase	—	Mar 16
Form 4	14.86%	844.68K	$24.75	$20.91M	Jan 25, 2021	6.53M	Purchase	—	Jan 21
Form 4	3.11%	160.00K	$16.05	$2.57M	Dec 22, 2020	5.68M	Purchase	—	Dec 18
Form 4	2.73%	146.75K	$11.75	$1.72M	Sep 17, 2020	5.52M	Purchase	—	Sep 15
Form 4	3.66%	189.65K	$11.10	$2.10M	Sep 14, 2020	5.38M	Purchase	—	Sep 10
Form 4	4.05%	201.91K	$11.17	$2.26M	Sep 08, 2020	5.19M	Purchase	—	Sep 03
Form 4	1.78%	87.25K	$15.20	$1.33M	Jun 10, 2020	4.99M	Purchase	—	Jun 08
Form 4	42.57%	1.46M	$14.00	$20.48M	Jun 03, 2020	4.90M	Purchase	—	Jun 01
Form 4	8.83%	278.73K	$16.15	$4.50M	Jan 21, 2020	3.44M	Purchase	—	Jan 16
Form 4	2.73%	83.96K	$14.98	$1.26M	Jan 15, 2020	3.16M	Purchase	—	Jan 13
Form 3	—	—	—	—	Jan 13, 2020	3.07M	—	—	—


Form 4	0.89%	17.81K	$2.25	$40.06K	Jun 22, 2017	2.03M	Purchase	—	Jun 20
Form 4	1.86%	72.65K	$2.29	$166.07K	Jun 07, 2017	3.98M	Purchase	—	Jun 05 - Jun 07
Form 4	1.24%	47.00K	$2.28	$106.53K	Jun 01, 2017	3.85M	Purchase	—	May 30 - May 31
Form 4	1.42%	78.86K	$2.30	$181.32K	May 19, 2017	5.62M	Purchase	—	May 17 - May 19
Form 4	2.08%	109.03K	$2.33	$253.43K	May 11, 2017	5.36M	Purchase	—	May 09 - May 11
Form 3	—	—	—	—	May 11, 2017	1.70M	—	—	—


Form 4	6.52%	1.23M	$5.19	$6.25M	Nov 17, 2023	20.04M	Purchase	—	Nov 15 - Nov 16
Form 4	9.61%	783.71K	$3.60	$2.82M	Nov 03, 2023	8.94M	Purchase	—	Nov 02
Form 4	1.86%	149.16K	$12.73	$1.90M	Jun 15, 2022	8.16M	Purchase	—	Jun 13
Form 4	29.77%	1.84M	$11.90	$21.86M	Jun 06, 2022	8.01M	Purchase	—	Jun 02 - Jun 06
Form 4	7.30%	420.00K	$8.50	$3.57M	May 20, 2022	6.17M	Purchase	—	May 18
Form 4	21.00%	997.96K	$14.10	$14.07M	Jan 21, 2022	5.75M	Purchase	—	Jan 19
Form 3	—	—	—	—	Nov 08, 2021	4.75M	—	—	—


Form 3	—	—	—	—	May 22, 2023	20.33M	—	—	—
Form 4	-1.00%	-50.00K	$4.50	-$224.97K	Sep 10, 2019	7.31M	Sale	—	Sep 06
Form 3	—	—	—	—	Sep 10, 2019	4.98M	—	—	—
Form 4	-72.48%	-5.00M	—	—	Feb 01, 2019	4.27M	Disposition	—	Jan 30
Form 3	—	—	—	—	Nov 26, 2018	6.89M	—	—	—


Form 4	—	—	—	—	Jun 20, 2018	2.90M	Acq/Dis	—	Jun 18
Form 3	—	—	—	—	Dec 08, 2017	2.90M	—	—	—


Form 4	-100.00%	-9.33M	$9.10	-$80.59M	Jun 28, 2023	—	Disposition	—	Jun 26
Form 4	—	80.00K	—	—	Apr 07, 2023	9.33M	Grant	—	Apr 05
Form 4	-1.45%	-129.24K	$6.12	-$52.02M	Aug 11, 2022	9.25M	Sale	—	Aug 09
Form 4	—	80.00K	—	—	Mar 11, 2022	9.38M	Grant	—	Mar 09
Form 4	35.51%	2.00M	$275.90	$5.08M	Apr 05, 2021	9.30M	Purchase	—	Apr 01
Form 4	—	80.00K	—	—	Mar 12, 2021	7.30M	Grant	—	Mar 10
Form 4	85.30%	1.92K	—	—	Mar 04, 2020	6.95M	Purchase	—	Mar 02 - Mar 04
Form 4	-19.25%	-1.65M	$3.00	$19.00M	Feb 12, 2018	6.94M	Disposition	—	Feb 09
Form 4	91.78%	4.12M	—	—	Jun 14, 2017	8.60M	Purchase	—	Jun 09
Form 4	1.41%	1.00M	$1.22	$1.22M	Jan 11, 2016	72.02M	Purchase	—	Jan 07 - Jan 08
Form 3	—	—	—	—	Dec 14, 2015	43.80M	—	—	—


Form 4	-1.49%	-46.41K	$18.00	-$835.36K	Feb 04, 2021	3.06M	Sale	—	Feb 02
Form 4	0.08%	2.53K	$13.32	$33.70K	Jul 02, 2020	3.11M	Purchase	—	Jun 30
Form 4	1.94%	118.00K	$14.16	$1.69M	Jun 22, 2020	6.19M	Purchase	—	Jun 19 - Jun 22
Form 3	—	—	—	—	Jun 22, 2020	2.99M	—	—	—


Form 4	-5.77%	-430.95K	$18.00	-$7.76M	Dec 11, 2020	7.03M	Sale	—	Dec 09
Form 3	—	—	—	—	Dec 04, 2020	7.47M	—	—	—
Form 4	-100.00%	-1.38K	—	—	Nov 20, 2020	7.07M	Disposition	—	Nov 20
Form 3	—	—	—	—	Nov 16, 2020	7.07M	—	—	—
Form 4	-15.36%	-1.07M	$15.79	-$16.92M	Feb 18, 2020	5.91M	Sale	—	Feb 13
Form 4	2.53%	342.07K	$9.46	$3.23M	Dec 12, 2019	13.84M	Purchase	—	Dec 10 - Dec 11
Form 3	—	—	—	—	Dec 12, 2019	6.64M	—	—	—


Form 4	—	358.29K	$40.75	$14.60M	Aug 22, 2024	6.49M	Purchase	—	Aug 20
Form 4	—	16.00K	—	—	Jun 28, 2024	6.13M	Grant	—	Jun 18
Form 4	—	979.01K	$25.25	$24.72M	Jan 09, 2024	6.12M	Purchase	—	Jan 05
Form 4	4.36%	414.11K	$12.85	$5.30M	Nov 06, 2023	10.00M	Purchase	—	Nov 02 - Nov 03
Form 4	—	12.00K	—	—	Jun 20, 2023	4.72M	Grant	—	Jun 15
Form 4	0.47%	41.01K	$30.57	$1.25M	Jan 13, 2023	9.08M	Purchase	—	Jan 11 - Jan 12
Form 4	13.46%	545.52K	$26.00	$14.18M	Aug 23, 2022	4.67M	Purchase	—	Aug 22
Form 4	—	12.00K	—	—	Jun 17, 2022	4.13M	Grant	—	Jun 15
Form 4	7.69%	289.43K	$14.34	$4.15M	May 31, 2022	4.11M	Purchase	—	May 26 - May 27
Form 4	0.27%	10.10K	$14.00	$141.39K	May 24, 2022	3.83M	Purchase	—	May 20
Form 4	7.13%	250.00K	$19.45	$4.87M	May 09, 2022	3.81M	Purchase	—	May 05 - May 06
Form 4	4.12%	130.31K	$38.96	$5.08M	Jan 31, 2022	3.56M	Purchase	—	Jan 27 - Jan 31
Form 4	9.43%	272.77K	$37.76	$10.30M	Jan 26, 2022	3.43M	Purchase	—	Jan 24
Form 4	21.28%	544.17K	$47.00	$25.58M	Jul 06, 2021	3.16M	Purchase	—	Jul 01
Form 4	—	20.06K	—	—	Jun 21, 2021	2.62M	Grant	—	Jun 16
Form 4	-0.03%	-661.00	$20.00	—	Aug 25, 2020	2.60M	Options	—	Aug 20 - Aug 21
Form 3	—	—	—	—	Aug 25, 2020	—	—	—	—


Form 4	-24.71%	-2.28M	$6.00	-$13.70M	May 26, 2020	6.96M	Sale	—	May 21
Form 4	2.12%	191.95K	$3.91	$750.85K	Nov 22, 2019	9.24M	Purchase	—	Nov 20
Form 4	1.44%	128.49K	$3.37	$433.00K	Nov 18, 2019	9.05M	Purchase	—	Nov 14
Form 4	16.36%	2.40M	$2.65	$6.31M	Oct 31, 2019	17.05M	Purchase	—	Oct 29 - Oct 30
Form 3	—	—	—	—	Jul 01, 2019	6.53M	—	—	—


Form 4	-14.37%	-386.29K	$10.70	-$4.13M	Jun 12, 2019	2.30M	Sale	—	Jun 10
Form 3	—	—	—	—	Apr 02, 2019	2.69M	—	—	—
Form 4	-42.92%	-1.28M	$26.65	-$34.19M	Dec 21, 2017	1.71M	Sale	—	Dec 19
Form 4	12.49%	331.92K	$15.84	$5.26M	Oct 23, 2017	2.99M	Purchase	—	Oct 19
Form 3	—	—	—	—	Sep 29, 2017	2.66M	—	—	—


Form 4	—	—	—	—	Feb 18, 2021	5.47M	—	—	—
Form 3	—	—	—	—	Dec 28, 2020	5.47M	—	—	—


Form 4	—	7.69K	—	—	Jun 10, 2024	21.71M	Grant	—	Jun 06
Form 4	—	11.30K	—	—	Jun 12, 2023	21.70M	Grant	—	Jun 08
Form 3	—	—	—	—	Apr 15, 2022	21.69M	—	—	—


Form 4	15.72%	1.27M	$2.60	$3.29M	Nov 06, 2020	9.32M	Purchase	—	Nov 04
Form 4	13.09%	932.61K	$2.75	$2.56M	Nov 03, 2020	8.06M	Purchase	—	Oct 30
Form 4	30.59%	1.67M	$3.18	$5.31M	Sep 09, 2019	7.12M	Purchase	—	Sep 05
Form 3	—	—	—	—	Aug 26, 2019	5.46M	—	—	—
Form 3	—	—	—	—	May 11, 2017	3.02M	—	—	—

Biotechnology Value Trading Fund OS LP's Net Worth

Who is Biotechnology Value Trading Fund OS LP

SEC CIK

Past Insider Trading and Trends

Allakos Inc.

Rain Oncology Inc.

IMMUNE DESIGN CORP.

Cascadian Therapeutics, Inc.

XOMA Corp

Xenon Pharmaceuticals Inc.

Cullinan Oncology, Inc.

Merus N.V.

Nivalis Therapeutics, Inc.

Repare Therapeutics Inc.

PIERIS PHARMACEUTICALS, INC.

Verastem, Inc.

Syndax Pharmaceuticals Inc

CTI BIOPHARMA CORP

IDEAYA Biosciences, Inc.

CYTOKINETICS INC

Kymera Therapeutics, Inc.

Calithera Biosciences, Inc.

CONCERT PHARMACEUTICALS, INC.

CytomX Therapeutics, Inc.

MoonLake Immunotherapeutics

GLYCOMIMETICS INC

Principia Biopharma Inc.

INFINITY PHARMACEUTICALS, INC.

Eledon Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

Regulus Therapeutics Inc.

ESSA Pharma Inc.

4D Molecular Therapeutics, Inc.

Third Harmonic Bio, Inc.

FIVE PRIME THERAPEUTICS, INC.

Structure Therapeutics Inc.

ARQULE INC

enGene Holdings Inc.

POINT Biopharma Global Inc.


Form 4	4.63%	2.27K	$35.79	$81.17K	Aug 20, 2020	51.20K	Purchase	—	Aug 18
Form 3	—	—	—	—	Aug 20, 2020	—	—	—	—


Form 4	—	—	—	—	Feb 19, 2021	8.26M	—	—	—
Form 4	-21.48%	-2.26M	$5.37	-$12.13M	Feb 16, 2021	8.26M	Sale	—	Feb 11
Form 4	-35.72%	-5.85M	$4.14	-$24.21M	Jan 26, 2021	10.52M	Sale	—	Jan 22
Form 4	1.17%	175.00K	$1.20	$209.91K	Dec 17, 2018	16.37M	Purchase	—	Dec 13
Form 4	1.56%	100.00K	$1.30	$130.00K	Nov 30, 2018	16.20M	Purchase	—	Nov 28
Form 4	3.65%	1.47M	$1.36	$2.01M	Nov 21, 2018	41.78M	Purchase	—	Nov 19 - Nov 21
Form 4	2.32%	905.93K	$1.35	$1.22M	Nov 15, 2018	41.15M	Purchase	—	Nov 13 - Nov 15
Form 4	17.08%	3.94M	$1.65	$6.50M	Jun 21, 2018	27.02M	Purchase	—	Jun 19 - Jun 21
Form 4	8.86%	1.51M	$1.95	$2.97M	Apr 11, 2018	18.55M	Purchase	—	Apr 09 - Apr 10
Form 4	11.20%	1.60M	$1.26	$2.01M	Oct 05, 2017	15.88M	Purchase	—	Oct 03 - Oct 04
Form 4	0.07%	4.38K	$1.34	$5.87K	Jan 05, 2017	6.67M	Purchase	—	Jan 03
Form 4	6.25%	742.40K	$1.34	$991.57K	Dec 30, 2016	12.63M	Purchase	—	Dec 28 - Dec 30
Form 4	3.88%	654.92K	$1.33	$855.49K	Dec 20, 2016	17.52M	Purchase	—	Dec 16 - Dec 20
Form 4	1.96%	201.39K	$1.19	$238.85K	Dec 02, 2016	10.48M	Purchase	—	Dec 01 - Dec 02
Form 3	—	—	—	—	Dec 02, 2016	5.07M	—	—	—


Form 4	48.84%	4.75M	$3.65	$17.35M	Oct 31, 2024	27.25M	Purchase	—	Oct 29
Form 4	183.29%	7.86M	—	—	May 13, 2024	22.50M	Purchase	—	May 09
Form 4	500.86%	11.57M	—	—	May 09, 2023	14.64M	Purchase	—	May 05
Form 3	—	—	—	—	Jan 31, 2022	2.31M	—	—	—
Form 4	401.10%	1.27M	—	—	Dec 28, 2020	1.74M	Options	—	Dec 22
Form 3	—	—	—	—	Oct 05, 2020	193.93K	—	—	—


Form 4	—	23.00K	—	—	Jun 18, 2024	9.05M	Grant	—	Jun 14
Form 4	22.02%	1.61M	$9.84	$14.82M	Sep 14, 2023	9.03M	Purchase	—	Sep 12 - Sep 14
Form 4	—	21.52K	—	—	Jun 21, 2023	7.42M	Grant	—	Jun 16
Form 4	3.02%	200.00K	$4.03	$806.90K	Jun 14, 2022	7.38M	Purchase	—	Jun 10
Form 4	11.64%	739.67K	$9.39	$6.95M	Dec 02, 2021	7.18M	Purchase	—	Nov 30
Form 4	—	99.56K	—	—	May 26, 2021	6.52M	Acq/Dis	—	Mar 31
Form 4	23.00%	1.20M	$19.00	—	Nov 20, 2020	6.42M	Purchase	—	Nov 18 - Nov 19
Form 3	—	—	—	—	Nov 19, 2020	—	—	—	—


Form 3	—	—	—	—	Aug 01, 2024	7.26M	—	—	—
Form 3	—	—	—	—	Jun 27, 2022	3.91M	—	—	—


Form 4	-23.05%	-1.00M	$14.30	-$14.30M	Oct 31, 2024	3.34M	Sale	—	Oct 29
Form 4	5.19%	214.06K	$4.11	$879.50K	Dec 22, 2022	4.34M	Purchase	—	Dec 20
Form 3	—	—	—	—	Dec 22, 2022	4.12M	—	—	—


Form 3	—	—	—	—	Mar 08, 2021	6.26M	—	—	—
Form 4	-85.66%	-7.39M	$20.19	-$149.25M	Nov 13, 2020	1.24M	Sale	—	Nov 11
Form 4	5.46%	446.56K	$4.89	$2.18M	Nov 06, 2020	8.63M	Purchase	—	Nov 04 - Nov 06
Form 4	4.40%	345.24K	$5.04	$1.74M	Oct 08, 2020	8.18M	Purchase	—	Oct 06
Form 4	0.01%	32.00	$3.80	$121.56	Sep 24, 2020	7.84M	Purchase	—	Sep 22
Form 4	3.89%	293.59K	$4.10	$1.20M	May 18, 2020	7.84M	Purchase	—	May 14
Form 4	7.33%	515.02K	$4.05	$2.09M	Dec 26, 2019	7.55M	Purchase	—	Dec 20
Form 4	1.96%	135.00K	$4.02	$542.36K	Dec 11, 2019	7.03M	Purchase	—	Dec 09
Form 4	19.39%	1.12M	$3.40	$3.81M	Nov 26, 2019	6.90M	Purchase	—	Nov 22
Form 4	20.14%	968.11K	$4.00	$3.87M	Nov 07, 2019	5.78M	Purchase	—	Nov 05
Form 4	0.20%	29.31K	$3.88	$113.81K	Oct 31, 2019	14.39M	Purchase	—	Oct 29 - Oct 31
Form 4	1.81%	169.37K	$3.75	$634.32K	Oct 25, 2019	9.53M	Purchase	—	Oct 23 - Oct 25
Form 4	4.78%	601.48K	$3.72	$2.25M	Oct 08, 2019	13.18M	Purchase	—	Oct 04 - Oct 08
Form 3	—	—	—	—	Oct 02, 2019	4.01M	—	—	—


Form 4	—	—	—	—	May 12, 2023	12.58M	Acq/Dis	—	May 10
Form 3	—	—	—	—	Feb 13, 2023	12.58M	—	—	—


Form 4	-10.71%	-1.04M	$5.00	-$5.18M	Jun 01, 2018	10.86M	Sale	—	May 30
Form 4	-18.73%	-2.23M	$3.10	-$6.91M	Apr 20, 2018	11.90M	Sale	—	Apr 18
Form 4	-16.20%	-2.30M	$2.90	-$6.67M	Apr 06, 2018	14.13M	Sale	—	Apr 04
Form 3	—	—	—	—	Oct 20, 2017	14.21M	—	—	—


Form 4	-100.00%	-17.16M	$12.45	-$213.66M	Dec 20, 2023	—	Sale	—	Dec 18
Form 3	—	—	—	—	Nov 06, 2023	17.16M	—	—	—